Literature DB >> 22976478

[Bone metastases treatment strategies].

A Leithner1, J Friesenbichler, D Andreou, W Maurer-Ertl, P U Tunn.   

Abstract

The primary goals of multimodal, interdisciplinary treatment of bone metastases are to achieve mobility, pain relief, and improve quality of life. In cooperation with radiotherapists and oncologists, an individual therapy plan has to be designed. As bone metastases are a sign of a systemic spread of the disease, cure is not possible in nearly all cases. A singular bone metastasis of a renal cell carcinoma may be regarded as an exemption, where wide resection might cure the patient. The extent of the operation should be based on the 3S principle "save, short & simple". The prognosis of survival should influence the treatment regime. If it is unclear whether a bone metastasis or a primary bone tumor is present, a biopsy is required.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22976478     DOI: 10.1007/s00132-012-1970-3

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  16 in total

1.  [Diagnostics and therapy of spinal metastases].

Authors:  H Pilge; B M Holzapfel; P M Prodinger; M Hadjamu; H Gollwitzer; H Rechl
Journal:  Orthopade       Date:  2011-02       Impact factor: 1.087

2.  Cancer statistics, 2012.

Authors:  Rebecca Siegel; Deepa Naishadham; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2012-01-04       Impact factor: 508.702

Review 3.  Biopsy of bone and soft tissue tumours: hints and hazards.

Authors:  Andreas Leithner; Werner Maurer-Ertl; Reinhard Windhager
Journal:  Recent Results Cancer Res       Date:  2009

4.  [Surgical treatment of pathologic fractures of the humerus and femur].

Authors:  G Gruber; M Zacherl; A Leithner; C Giessauf; M Glehr; H Clar; R Windhager
Journal:  Orthopade       Date:  2009-04       Impact factor: 1.087

Review 5.  The threat of misdiagnosis of primary osteosarcoma over the age of 60: a series of seven cases and review of the literature.

Authors:  Patrick Sadoghi; Andreas Leithner; Heimo Clar; Mathias Glehr; Christine Wibmer; Koppany Bodo; Franz Quehenberger; Reinhard Windhager
Journal:  Arch Orthop Trauma Surg       Date:  2009-11-28       Impact factor: 3.067

6.  Predictive value of seven preoperative prognostic scoring systems for spinal metastases.

Authors:  Andreas Leithner; Roman Radl; Gerald Gruber; Markus Hochegger; Katharina Leithner; Heike Welkerling; Peter Rehak; Reinhard Windhager
Journal:  Eur Spine J       Date:  2008-09-12       Impact factor: 3.134

7.  Metastatic patterns in adenocarcinoma.

Authors:  Kenneth R Hess; Gauri R Varadhachary; Sarah H Taylor; Wei Wei; Martin N Raber; Renato Lenzi; James L Abbruzzese
Journal:  Cancer       Date:  2006-04-01       Impact factor: 6.860

8.  Critical evaluation of Mirels' rating system for impending pathologic fractures.

Authors:  Timothy A Damron; Hannah Morgan; Dave Prakash; William Grant; Jesse Aronowitz; John Heiner
Journal:  Clin Orthop Relat Res       Date:  2003-10       Impact factor: 4.176

9.  Survival after surgery for spinal and extremity metastases. Prognostication in 241 patients.

Authors:  H C Bauer; R Wedin
Journal:  Acta Orthop Scand       Date:  1995-04

10.  Incidence of bone metastases and skeletal-related events in breast cancer patients: a population-based cohort study in Denmark.

Authors:  Annette Ø Jensen; Jacob B Jacobsen; Mette Nørgaard; Mellissa Yong; Jon P Fryzek; Henrik T Sørensen
Journal:  BMC Cancer       Date:  2011-01-24       Impact factor: 4.430

View more
  3 in total

1.  [Surgical treatment of skeletal metastases].

Authors:  T Gösling; M Becker-Schiebe
Journal:  Unfallchirurg       Date:  2015-04       Impact factor: 1.000

Review 2.  [Operative therapy of spinal metastases from urological tumors].

Authors:  R H Richter; M Hammon; M Uder; J Huber; P J Goebell; F Kunath; B Wullich; B Keck
Journal:  Urologe A       Date:  2016-02       Impact factor: 0.639

Review 3.  [Differentiated treatment strategies for bone metastases of the extremities].

Authors:  B Rath; M Tingart; F Migliorini; J Eschweiler; R Zureik; J Hardes
Journal:  Orthopade       Date:  2019-09       Impact factor: 1.087

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.